Literature DB >> 11268000

Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation.

X Xia1, A Cheng, T Lessor, Y Zhang, A W Hamburger.   

Abstract

Ebp1, an ErbB-3 binding protein, inhibits the proliferation and induces the differentiation of human breast cancer cells. The mechanisms of these effects are unknown. Rb, the product of the retinoblastoma gene, is an important modulator of cell cycle progression and cellular differentiation. We report that Rb is a binding target for Ebp1. Ebp1 was localized to both the nucleus and the cytoplasm of logarithmically growing AU565 breast cancer cells and HeLa cells as determined by confocal immunofluorescent microscopy. Ebp1 was present in Rb immunoprecipitates derived from AU565 breast cancer cells. GST-Rb also bound endogenous Ebp1. Using GST-Ebp1 constructs, we determined that the 72 C-terminal amino acids of Ebp1 were sufficient to bind Rb. Dephosphorylation of Ebp1 enhanced the interaction of Ebp1 with Rb. The overexpression of Ebp1 in MCF-7 and AU565 (Rb(+)) cells inhibited the activity of the E2F1 regulated cyclin-E promoter. Ebp1 bound E2F1 indirectly via Rb in lysates of MCF-7 cells. The interaction of Ebp1 with Rb may prove to be an important mechanism of Ebp1 induced changes in cell proliferation and differentiation. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11268000     DOI: 10.1002/jcp.1075

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  48 in total

1.  The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

Authors:  Smita Awasthi; Heather Ezelle; Bret A Hassel; Anne W Hamburger
Journal:  Mol Cell Biochem       Date:  2015-04-17       Impact factor: 3.396

2.  Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes.

Authors:  Sudeep K Bose; Tapas K Sengupta; Sumita Bandyopadhyay; Eleanor K Spicer
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

3.  Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase.

Authors:  Jee-Yin Ahn; Xia Liu; Zhixue Liu; Lorena Pereira; Dongmei Cheng; Junmin Peng; Paul A Wade; Anne W Hamburger; Keqiang Ye
Journal:  EMBO J       Date:  2006-04-27       Impact factor: 11.598

4.  Ebp1 isoforms distinctively regulate cell survival and differentiation.

Authors:  Zhixue Liu; Jee-Yin Ahn; Xia Liu; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

Review 5.  The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.

Authors:  Anne W Hamburger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-04-19       Impact factor: 2.673

6.  Expression, purification, crystallization and preliminary crystallographic analysis of the proliferation-associated protein Ebp1.

Authors:  Eva Kowalinski; Gert Bange; Klemens Wild; Irmgard Sinning
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-25

Review 7.  A structural view of PA2G4 isoforms with opposing functions in cancer.

Authors:  Brendan W Stevenson; Michael A Gorman; Jessica Koach; Belamy B Cheung; Glenn M Marshall; Michael W Parker; Jessica K Holien
Journal:  J Biol Chem       Date:  2020-09-20       Impact factor: 5.157

8.  Pa2G4 is a novel Six1 co-factor that is required for neural crest and otic development.

Authors:  Karen M Neilson; Genevieve Abbruzzesse; Kristy Kenyon; Vanessa Bartolo; Patrick Krohn; Dominique Alfandari; Sally A Moody
Journal:  Dev Biol       Date:  2016-12-09       Impact factor: 3.582

9.  Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice.

Authors:  Yuexing Zhang; Yan Lu; Hua Zhou; Myounghee Lee; Zhenqiu Liu; Bret A Hassel; Anne W Hamburger
Journal:  BMC Cell Biol       Date:  2008-12-18       Impact factor: 4.241

10.  Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.

Authors:  S-M Oh; Z Liu; M Okada; S-W Jang; X Liu; C-B Chan; H Luo; K Ye
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.